NRS 439B.635
Manufacturer of certain essential diabetes drugs to prepare and submit annual report.

On or before April 1 of each year, the manufacturer of a prescription drug that appears on the most current list compiled by the Department pursuant to subsection 1 of NRS 439B.630 shall prepare and submit to the Department, in the form prescribed by the Department, a report which must include:

1.

The costs of producing the drug;

2.

The total administrative expenditures relating to the drug, including marketing and advertising costs;

3.

The profit that the manufacturer has earned from the drug and the percentage of the manufacturer’s total profit for the period during which the manufacturer has marketed the drug for sale that is attributable to the drug;

4.

The total amount of financial assistance that the manufacturer has provided through any patient prescription assistance program;

5.

The cost associated with coupons provided directly to consumers and for programs to assist consumers in paying copayments, and the cost to the manufacturer attributable to the redemption of those coupons and the use of those programs;

6.

The wholesale acquisition cost of the drug;

7.

A history of any increases in the wholesale acquisition cost of the drug over the 5 years immediately preceding the date on which the report is submitted, including the amount of each such increase expressed as a percentage of the total wholesale acquisition cost of the drug, the month and year in which each increase became effective and any explanation for the increase;

8.

The aggregate amount of all rebates that the manufacturer has provided to pharmacy benefit managers for sales of the drug within this State; and

9.

Any additional information prescribed by regulation of the Department for the purpose of analyzing the cost of prescription drugs that appear on the list compiled pursuant to subsection 1 of NRS 439B.630, trends in those costs and rebates available for such drugs.

Source: Section 439B.635 — Manufacturer of certain essential diabetes drugs to prepare and submit annual report., https://www.­leg.­state.­nv.­us/NRS/NRS-439B.­html#NRS439BSec635 (accessed May 26, 2025).

439B.600
Definitions. 439B.605
“Manufacturer” defined. 439B.610
“Pharmacy” defined. 439B.615
“Pharmacy benefit manager” defined. 439B.620
“Wholesale acquisition cost” defined. 439B.625
Organization representing interests of retail merchants to prepare and update list of most commonly prescribed drugs or generic equivalents. 439B.630
Department to annually compile lists of certain prescription drugs essential for treating asthma and diabetes. 439B.635
Manufacturer of certain essential diabetes drugs to prepare and submit annual report. 439B.640
Manufacturer of essential diabetes drug that has undergone significant price increase to submit report. 439B.645
Pharmacy benefit manager to submit annual report concerning essential diabetes drugs. 439B.650
Department to compile report concerning price of essential asthma and diabetes drugs. 439B.655
Pharmacies to provide to Department contact information, electronic mail address and address of Internet website 439B.660
Manufacturer required to provide list of its pharmaceutical sales representatives 439B.665
Report by certain nonprofit organizations that receive items of value from manufacturer. 439B.670
Department to place on Internet website certain information concerning pharmacies, nonprofit organizations and prescription drugs and certain reports by Department 439B.675
Manner of presentation of information. 439B.680
Immunity from civil and criminal liability. 439B.685
Regulations. 439B.690
Suspension of components of program or duties of Department if sufficient money not available 439B.695
Penalty for failure to provide information to Department.

May 26, 2025

§ 439B.635. Mfr. of certain essential diabetes drugs to prepare & submit annual report.'s source at nv​.us